Recent centuries have witnessed remarkable developments in the management of muscular dystrophy. Researchers are actively studying innovative strategies that hold hope for improving the lives of individuals stricken by this progressive illness. Drug development have emerged as particularly potent directions for tackling the underlying mechanisms of